Get a Scoping Call
Back
Drug Discovery · Simulation Study

Stop synthesising compounds that were never going to work.

Simulation studies for binding affinity prediction, ADMET screening, and lead optimisation, reducing attrition before you enter the wet lab.

Grab a scoping call
320×
Fewer compounds screened to find the same hits (ABFE vs full-deck HTS, A2AR benchmark)
4.4×
Hit rate vs blind HTS (14–18% confirmed vs 3.2% industry average, ABFE screen)
0.9 kcal/mol
RBFE mean unsigned error, kinase series (validated against X-ray crystallography)
Applications

What we can study for you

  • Binding affinity screening with FEP-level accuracy
  • ADMET profiling for metabolic stability and permeability
  • Free energy perturbation for lead optimisation campaigns
  • Aqueous solubility prediction across compound libraries
  • hERG cardiac liability assessment from molecular structure
  • Scaffold hopping with preserved binding mode validation
Our Approach

Computation before synthesis, not after

We run simulation studies that score and rank compounds before you commit to synthesis. Binding free energies, ADMET properties, and metabolic liabilities are computed at chemical accuracy, so your medicinal chemistry team synthesises the right molecules first, not the obvious ones.

  • Free energy perturbation with chemical accuracy for relative and absolute binding affinities, including charge-changing perturbations and large scaffold hops
  • Quantum-mechanical ADMET prediction for metabolic stability, membrane permeability, and hERG liability
  • Solvent mapping and binding site analysis to identify druggable pockets and guide fragment-based design
  • Full lead optimisation campaigns scored computationally: hundreds of analogues ranked before a single compound is synthesised
Studies We Offer

Specific studies, fixed scope.

2–4 week study
Target Selectivity & Binding Affinity Screening

Computationally screening molecules against intended targets to eliminate low-probability candidates before synthesis.

2–3 week study
Off-Target Toxicity (ADMET) Profiling

Predicting severe side effects, including cardiac toxicity and hepatotoxicity, before clinical trials begin.

Describe your Drug Discovery challenge.

We'll scope a study within 48 hours and tell you whether our platform can help. No commitment required.

Grab a scoping call

or email [email protected]